JP2010505848A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010505848A5 JP2010505848A5 JP2009531464A JP2009531464A JP2010505848A5 JP 2010505848 A5 JP2010505848 A5 JP 2010505848A5 JP 2009531464 A JP2009531464 A JP 2009531464A JP 2009531464 A JP2009531464 A JP 2009531464A JP 2010505848 A5 JP2010505848 A5 JP 2010505848A5
- Authority
- JP
- Japan
- Prior art keywords
- mrs
- intraocular pressure
- eye
- administering
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US85017506P | 2006-10-06 | 2006-10-06 | |
| PCT/US2007/021409 WO2008045330A2 (en) | 2006-10-06 | 2007-10-05 | Effective delivery of cross-species a3 adenosine-receptor antagonists to reduce intraocular pressure |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010505848A JP2010505848A (ja) | 2010-02-25 |
| JP2010505848A5 true JP2010505848A5 (cg-RX-API-DMAC7.html) | 2010-11-25 |
Family
ID=39283379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009531464A Pending JP2010505848A (ja) | 2006-10-06 | 2007-10-05 | 眼内圧を低下させるための種交差性a3アデノシン受容体アンタゴニストの効果的送達 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20090258836A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2076267A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2010505848A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007307157A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0715318A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2665616A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2009003750A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2008045330A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013516495A (ja) | 2010-01-11 | 2013-05-13 | イノテック ファーマシューティカルズ コーポレイション | 眼圧を低下させる組合せ、キット、および方法 |
| JP2013523739A (ja) * | 2010-03-26 | 2013-06-17 | イノテック ファーマシューティカルズ コーポレイション | N6−シクロペンチルアデノシン(cpa)、cpa誘導体またはそれらのプロドラッグを用いてヒトにおける眼内圧を低下させる方法 |
| SMT201700377T1 (it) | 2012-01-26 | 2017-09-07 | Inotek Pharmaceuticals Corp | Polimorfi anidri di (2r,3s,4r,5r)-5-(6-(ciclopentilammino)-9h-purin-9-il)-3,4- diidrossitetraidrofuran-2-il)}metil nitrato e processi di sua preparazione |
| NZ630759A (en) | 2013-03-15 | 2017-07-28 | Inotek Pharmaceuticals Corp | Ophthalmic formulations comprising an a1 agonist |
| ES2578363B1 (es) | 2015-01-22 | 2017-01-31 | Palobiofarma, S.L. | Moduladores de los receptores A3 de adenosina |
| US10196396B2 (en) | 2016-01-14 | 2019-02-05 | Handok Inc. | Compounds antagonizing A3 adenosine receptor, method for preparing them, and medical-use thereof |
| ES2676535B1 (es) | 2017-01-20 | 2019-04-29 | Palobiofarma Sl | Moduladores de los receptores a3 de adenosina |
| KR101805400B1 (ko) * | 2017-03-21 | 2017-12-07 | 퓨쳐메디신 주식회사 | 아데노신 유도체를 포함하는 녹내장 예방 및 치료용 약학적 조성물 |
| CN109666053A (zh) * | 2017-10-16 | 2019-04-23 | 张家口华健致远生物科技有限公司 | 一种a3腺苷受体激动剂及其用途 |
| KR102007640B1 (ko) * | 2017-11-29 | 2019-08-07 | 퓨쳐메디신 주식회사 | 아데노신 유도체를 포함하는 망막 질환 또는 시신경 질환 예방 및 치료용 약학적 조성물 |
| US11395597B2 (en) * | 2018-06-26 | 2022-07-26 | General Electric Company | System and method for evaluating blood flow in a vessel |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4431638B2 (ja) * | 1996-01-29 | 2010-03-17 | アメリカ合衆国 | ジヒドロピリジン―、ピリジン―、ベンゾピラン―オン―およびトリアゾロキナゾリン誘導体、それらの製造およびそれらのアデノシン受容体アンタゴニストとしての用途 |
| EP1096975B1 (en) * | 1998-07-16 | 2005-03-16 | The Trustees Of The University Of Pennsylvania | Use of a3 adenosine receptor antagonists in the manufacture of a medicament for reducing intraocular pressure |
| IL133680A0 (en) * | 1999-09-10 | 2001-04-30 | Can Fite Technologies Ltd | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
-
2007
- 2007-10-05 BR BRPI0715318-0A patent/BRPI0715318A2/pt not_active IP Right Cessation
- 2007-10-05 AU AU2007307157A patent/AU2007307157A1/en not_active Abandoned
- 2007-10-05 WO PCT/US2007/021409 patent/WO2008045330A2/en not_active Ceased
- 2007-10-05 EP EP07852549.0A patent/EP2076267A4/en not_active Withdrawn
- 2007-10-05 JP JP2009531464A patent/JP2010505848A/ja active Pending
- 2007-10-05 MX MX2009003750A patent/MX2009003750A/es active IP Right Grant
- 2007-10-05 CA CA002665616A patent/CA2665616A1/en not_active Abandoned
-
2009
- 2009-04-06 US US12/419,062 patent/US20090258836A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12006328B2 (en) | Thieno[2,3-d]pyrimidin-4-one derivatives as NMDAR modulators and uses related thereto | |
| RU2470635C2 (ru) | Профилактическое или терапевтическое средство, применяемое при заболеваниях заднего отдела глаза | |
| WO2008045330A3 (en) | Effective delivery of cross-species a3 adenosine-receptor antagonists to reduce intraocular pressure | |
| JP6466504B2 (ja) | 長時間の眼圧低下効果を有するアルファ−2アドレナリンアゴニスト | |
| PT1511481E (pt) | Utilização oftalmológica de roflumilast para o tratamento de doenças do olho | |
| WO2017106306A1 (en) | Methods of treating hyperalgesia | |
| KR20070005911A (ko) | 개선된 비-진정성 알파-2 효능제의 신규 동정 방법 | |
| JP2009504748A5 (cg-RX-API-DMAC7.html) | ||
| AU2023201678B2 (en) | Methods for the use of 5'-adenosine diphosphate ribose (ADPR) | |
| JP2013500977A5 (cg-RX-API-DMAC7.html) | ||
| JP7858508B2 (ja) | 近視の治療、近視の予防および/または近視の進行抑制のための医薬 | |
| CN1143321A (zh) | 用5-ht2拮抗剂治疗观念与行为强迫症的方法 | |
| JP2018538354A (ja) | Cftr制御因子及びこの使用方法 | |
| TR201809003T4 (tr) | Motor bozukluklar için terapötik madde. | |
| JP2010520174A5 (cg-RX-API-DMAC7.html) | ||
| CN102822188A (zh) | 腺苷化合物及其用途 | |
| KR20240134157A (ko) | 파킨슨 치료제의 개선된 코 투여 | |
| JP4308255B2 (ja) | ムスカリン受容体作動薬を含有する眼科用経皮吸収型製剤 | |
| JP6832336B2 (ja) | アルコール乱用の治療におけるγ−ヒドロキシ酪酸の選択されたアミドおよびその使用 | |
| US20250353861A1 (en) | Derivative of artemisinin and preparation method and use thereof | |
| JP2009500398A5 (cg-RX-API-DMAC7.html) | ||
| JP2009500397A5 (cg-RX-API-DMAC7.html) | ||
| KR101891078B1 (ko) | 황반변성 예방 또는 치료용 약학 조성물 | |
| WO2008086341A1 (en) | Methods. compositions, and formulations for preventing or reducing adverse effects in a patient | |
| DE60318033T2 (de) | Biguanid-derivate und deren verwendung als antidiabetika |